Cancer
4 articles
Advertisement
Articles4
Melanoma Immunotherapy Left Half of Patients With Lasting Side Effects. A Study Asks Who.
In 303 patients treated after surgery, 48% had side effects that persisted after stopping, most often thyroid...
AM
3 Oct
Infections Caused 2.3 Million Cancers in 2024, and a Larger Share in Southeast Asia
An IARC analysis in The Lancet Oncology attributes one in eight new tumours worldwide to infectious agents. In...
AM
1 Oct
A Drug Aimed at a Weak Point in Some Cancers Shrank Tumours in 7 of 66 Patients
The first WRN inhibitor tested in people was tolerable and controlled disease in 74% of patients whose MSI can...
AM
30 Sep
A Korean Group's US Subsidiary Wins FDA Approval for a Bile-Duct Cancer Drug
Lyrfigtu shrank tumours in 46 per cent of patients in a trial with no comparison group. HLB calls it a first f...
AM
27 Sep
Advertisement